Drug recall · October 23, 2019
Fentanyl Citrate USP recall
Why: CGMP Deviations: Received notice from supplier that there is potential glass contamination.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fentanyl Citrate USP, Active Pharmaceutical Ingredient, Spectrum Chemical MFG. CORP., Gardena, CA 90248 NDC 49452-0032-06
- Lots / codes
Lot # 1HE0899, 1IB0005, Exp 02/28/2023
- Quantity
- 29.1 grams
- Company
- Spectrum Laboratory Products, Gardena, CA
- Distribution
- Product was distributed to compounding pharmacies and labs in CA, CO, MD, SC.
- Initiated
- September 12, 2019 · Voluntary: Firm initiated
- Classified
- October 15, 2019
- Reported
- October 23, 2019
- Ended
- November 10, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fentanyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.